Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Acta Neurologica Belgica
Published in: Acta Neurologica Belgica 5/2020

01-10-2020 | Guillain-Barré Syndrome | Review article

Neurological manifestations of COVID-19, SARS and MERS

Authors: Kato Verstrepen, Laure Baisier, Harald De Cauwer

Published in: Acta Neurologica Belgica | Issue 5/2020

Login to get access

Abstract

Since December 2019, the world is affected by an outbreak of a new disease named COVID-19, which is an acronym of ‘coronavirus disease 2019’. Coronaviruses (CoV) were assumed to be associated with mild upper respiratory tract infections, such as common cold. This perception changed in time due to occurrence of the Severe Acute Respiratory Syndrome (SARS) caused by SARS-CoV in 2002 and the Middle East Respiratory Syndrome (MERS) caused by MERS-CoV in 2012, both inducing an epidemic severe viral pneumonia with potentially respiratory failure and numerous extra-pulmonary manifestations. The novel coronavirus, SARS-CoV-2, is likewise a causative pathogen for severe viral pneumonia with the risk of progression to respiratory failure and systemic manifestations. In this review, we will give a summary of the neurological manifestations due to SARS and MERS, as those might predict the neurological outcome in the novel COVID-19. Additionally, we provide an overview of the current knowledge concerning neurological manifestations associated with COVID-19, to the extent that literature is already available as the pandemic is still ongoing.
Literature
1.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). StatPearls. Treasure Island (FL): StatPearls Publishing. StatPearls Publishing LLC
2.
3.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 395(10224):565–574CrossRef
4.
Bradley BT, Bryan A (2019) Emerging respiratory infections: the infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella. Semin Diagn Pathol 36(3):152–159PubMedPubMedCentralCrossRef
5.
6.
Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M et al (2019) Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 12(1):14PubMedCentralCrossRef
7.
8.
Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H (2004) Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 113(1 Pt 1):e73–e76PubMed
9.
10.
Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ (2014) Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res 194:145–158PubMedPubMedCentralCrossRef
11.
12.
Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian journal of pediatrics. 2020
13.
14.
Xu J, Zhong S, Liu J, Li L, Li Y, Wu X et al (2005) Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin infect Dis 41(8):1089–1096PubMedCrossRef
15.
Hung EC, Chim SS, Chan PK, Tong YK, Ng EK, Chiu RW et al (2003) Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 49(12):2108–2109PubMedPubMedCentralCrossRef
16.
17.
Tsai LK, Hsieh ST, Chao CC, Chen YC, Lin YH, Chang SC et al (2004) Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol 61(11):1669–1673PubMedCrossRef
18.
Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM et al (2003) A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348(20):1986–1994PubMedCrossRef
19.
Leung TW, Wong KS, Hui AC, To KF, Lai ST, Ng WF et al (2005) Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch Neurol 62(7):1113–1117PubMedCrossRef
20.
21.
de Bock F, Derijard B, Dornand J, Bockaert J, Rondouin G (1998) The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-alpha. Eur J Neurosci 10(10):3107–3114PubMedCrossRef
22.
Levy D, Höke A, Zochodne DW (1999) Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett 260(3):207–209PubMedCrossRef
23.
Singh U, Scheld WM (1996) Infectious Etiologies of Rhabdomyolysis: three Case Reports and Review. Clin Infect Dis 22(4):642–649PubMedCrossRef
24.
25.
Hwang CS (2006) Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan 15(1):26–28PubMed
26.
Dalakas MC, Clark WM (2003) Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record. Neurology 60(11):1736–1737PubMedCrossRef
27.
Umapathi T, Kor AC, Venketasubramanian N, Lim CC, Pang BC, Yeo TT et al (2004) Large artery ischaemic stroke in severe acute respiratory syndrome (SARS). J Neurol 251(10):1227–1231PubMedPubMedCentralCrossRef
28.
Moldofsky H, Patcai J (2011) Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol 11:37PubMedPubMedCentralCrossRef
29.
Lo YL, Leong HN, Hsu LY, Tan TT, Kurup A, Fook-Chong S et al (2005) Autonomic dysfunction in recovered severe acute respiratory syndrome patients. Canad J Neurol Sci 32(2):264PubMedCrossRef
30.
Choi KW, Chau TN, Tsang O, Tso E, Chiu MC, Tong WL et al (2003) Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 139(9):715–723PubMedCrossRef
31.
32.
Algahtani H, Subahi A, Shirah B (2016) Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med 2016:3502683PubMedPubMedCentral
33.
Joob B, Wiwanitkit V (2015) Neurologic syndrome due to MERS: is there a possibility that the virus can cross the blood-brain barrier to cause a neurological problem? Ann Trop Med Publ Health 8(5):231CrossRef
34.
Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA et al (2014) Clinical aspects and outcomes of 70 patients with middle east respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 29:301–306PubMedPubMedCentralCrossRef
35.
Arabi YM, Harthi A, Hussein J, Bouchama A, Johani S, Hajeer AH et al (2015) Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 43(4):495–501PubMedPubMedCentralCrossRef
36.
37.
Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R et al (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495(7440):251–254PubMedPubMedCentralCrossRef
38.
Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM et al (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60(7):1917–1925PubMedPubMedCentralCrossRef
39.
Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH et al (2017) Neurological Complications during Treatment of Middle East Respiratory Syndrome. Journal of clinical neurology (Seoul, Korea). 13(3):227–233PubMedCrossRefPubMedCentral
40.
Briani C, Chemello L, Zara G, Ermani M, Bernardinello E, Ruggero S et al (2006) Peripheral neurotoxicity of pegylated interferon alpha. A prospective study in patients with HCV. Neurology 67(5):781–785PubMedCrossRef
41.
Meriggioli MN, Rowin J (2000) Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve 23(3):433–435PubMedCrossRef
42.
Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR (2008) Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol 14(2):318–321PubMedPubMedCentralCrossRef
43.
Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC et al (2008) Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol 64(5):566–572PubMedPubMedCentralCrossRef
44.
Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11(7):995–998PubMedCrossRef
45.
Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264–7275PubMedPubMedCentralCrossRef
46.
Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv. 2020:2020.02.22.20026500
47.
Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92(6):552–555PubMedCrossRef
48.
Lüers JC, Klußmann JP, Guntinas-Lichius O (2020) The Covid-19 pandemic and otolaryngology: What it comes down to? Laryngo- Rhino- Otologie. 99(5):287–291PubMedCrossRef
49.
Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19(5):383–384PubMedPubMedCentralCrossRef
50.
El Otmani H, El Moutawakil B, Rafai MA, El Benna N, El Kettani C, Soussi M et al (2020) Covid-19 and Guillain-Barré syndrome: more than a coincidence! Revue neurologique. 176(6):518–519PubMedPubMedCentralCrossRef
51.
Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S et al (2020) Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci 2020:1–4
52.
53.
54.
55.
Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S (2020) Cerebral venous sinus thrombosis as a presentation of COVID-19. European J Case Rep int Med 7(5):001691
56.
Pranata R, Huang I, Lim MA, Wahjoepramono PEJ, July J (2020) Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 - systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis 2020:104949CrossRef
Metadata
Title
Neurological manifestations of COVID-19, SARS and MERS
Authors
Kato Verstrepen
Laure Baisier
Harald De Cauwer
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 5/2020
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-020-01412-4

Other articles of this Issue 5/2020

Acta Neurologica Belgica 5/2020 Go to the issue

Original article

Red cell distribution width levels in Parkinson’s disease patients

Letter to the Editor

Linezolid-induced status epilepticus

Letter to the Editor

Acute idiopathic maculopathy during the treatment of intracranial tuberculomas masquerading as malignant glioma

Original article

Practices and opinions about disclosure of the diagnosis of Alzheimer’s disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementia

Letter to the Editor

A British family with familial cerebral cavernous malformation due to a rare mutation of the CCM2 gene

Letter to the Editor

Delayed encephalopathy after carbon monoxide intoxication: case report